Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Kala Bio Inc (NQ: KALA ) 6.980 +0.150 (+2.20%) Streaming Delayed Price Updated: 9:56 AM EDT, Jul 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 11,854 Open 6.990 Bid (Size) 6.860 (1) Ask (Size) 6.990 (1) Prev. Close 6.830 Today's Range 6.780 - 6.990 52wk Range 4.210 - 15.94 Shares Outstanding 2,816,454 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News KALA BIO Announces $12,500,000 Private Placement June 27, 2024 From KALA BIO, Inc. Via GlobeNewswire KALA BIO to Present at Jefferies Global Healthcare Conference May 29, 2024 From KALA BIO, Inc. Via GlobeNewswire Performance YTD +0.43% +0.43% 1 Month +34.23% +34.23% 3 Month +2.50% +2.50% 6 Month -17.13% -17.13% 1 Year -51.76% -51.76% More News Read More KALA Stock Earnings: Kala Pharmaceuticals Misses EPS for Q1 2024 May 14, 2024 Via InvestorPlace KALA BIO Reports First Quarter 2024 Financial Results and Provides Corporate Update May 14, 2024 From KALA BIO, Inc. Via GlobeNewswire Kala Bio: Q3 Earnings Insights November 13, 2023 Via Benzinga Kala Pharmaceuticals: Q1 Earnings Insights May 09, 2023 Via Benzinga KALA Stock Earnings: Kala Pharmaceuticals Beats EPS for Q4 2023 April 02, 2024 Via InvestorPlace KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update March 29, 2024 From KALA BIO, Inc. Via GlobeNewswire KALA BIO to Present at TD Cowen 44th Annual Healthcare Conference February 26, 2024 From KALA BIO, Inc. Via GlobeNewswire KALA BIO to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference February 06, 2024 From KALA BIO, Inc. Via GlobeNewswire KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) January 19, 2024 From KALA BIO, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Tuesday's Intraday Session December 05, 2023 Via Benzinga KALA BIO Reports Third Quarter 2023 Financial Results and Provides Corporate Update November 13, 2023 From KALA BIO, Inc. Via GlobeNewswire KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) September 20, 2023 From KALA BIO, Inc. Via GlobeNewswire KALA BIO to Present at H.C. Wainwright 25th Annual Global Investment Conference September 05, 2023 From KALA BIO, Inc. Via GlobeNewswire KALA BIO Reports Second Quarter 2023 Financial Results and Provides Corporate Update August 04, 2023 From KALA BIO, Inc. Via GlobeNewswire KALA BIO to Participate in Upcoming Investor Conferences in August August 02, 2023 From KALA BIO, Inc. Via GlobeNewswire Kala Pharmaceuticals Announces Name Change to KALA BIO August 02, 2023 From Kala Pharmaceuticals, Inc. Via GlobeNewswire 10 Short Squeeze Stocks To Watch: Aeglea Biotherapeutics, Toro Corp, AirSculpt, A Company Moves Up 4,166 Positions & More July 24, 2023 Via Benzinga Kala Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) July 19, 2023 From Kala Pharmaceuticals, Inc. Via GlobeNewswire Kala Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) June 23, 2023 From Kala Pharmaceuticals, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Friday's Intraday Session June 02, 2023 Via Benzinga Kala Pharmaceuticals to Present at the Jefferies Healthcare Conference June 02, 2023 From Kala Pharmaceuticals, Inc. Via GlobeNewswire 10 Short Squeeze Stocks To Watch: Toro Corp, PaxMedica, Getty Images And More May 15, 2023 Via Benzinga Kala Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update May 09, 2023 From Kala Pharmaceuticals, Inc. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
